ITMI932154A0 - Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva - Google Patents

Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Info

Publication number
ITMI932154A0
ITMI932154A0 ITMI932154A ITMI932154A ITMI932154A0 IT MI932154 A0 ITMI932154 A0 IT MI932154A0 IT MI932154 A ITMI932154 A IT MI932154A IT MI932154 A ITMI932154 A IT MI932154A IT MI932154 A0 ITMI932154 A0 IT MI932154A0
Authority
IT
Italy
Prior art keywords
immunomodulating
reactive protein
protein fragments
oligopeptides derived
oligopeptides
Prior art date
Application number
ITMI932154A
Other languages
English (en)
Inventor
Patrizia Caretto
Flavio Leoni
Fabrizio Marcucci
Gianni Gromo
Paolo Mascagni
Massimo Pinori
Silvana Cappelletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of ITMI932154A0 publication Critical patent/ITMI932154A0/it
Priority to ITMI932154A priority Critical patent/IT1271486B/it
Priority to AU68441/94A priority patent/AU684511B2/en
Priority to AT94916966T priority patent/ATE226591T1/de
Priority to ES94916966T priority patent/ES2185652T3/es
Priority to DE69431603T priority patent/DE69431603T2/de
Priority to JP50541495A priority patent/JP3221881B2/ja
Priority to PT94916966T priority patent/PT723552E/pt
Priority to CA002173939A priority patent/CA2173939C/en
Priority to US08/624,405 priority patent/US6057295A/en
Priority to HU9600934A priority patent/HUT75538A/hu
Priority to CN94193726A priority patent/CN1041524C/zh
Priority to KR1019960701879A priority patent/KR100363408B1/ko
Priority to PCT/EP1994/001574 priority patent/WO1995010531A1/en
Priority to DK94916966T priority patent/DK0723552T3/da
Priority to EP94916966A priority patent/EP0723552B1/en
Priority to IL10976194A priority patent/IL109761A0/xx
Priority to ZA943610A priority patent/ZA943610B/xx
Publication of ITMI932154A1 publication Critical patent/ITMI932154A1/it
Priority to FI961584A priority patent/FI961584A/fi
Priority to NO961423A priority patent/NO961423L/no
Application granted granted Critical
Publication of IT1271486B publication Critical patent/IT1271486B/it
Priority to US09/439,164 priority patent/US6342481B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4737C-reactive protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI932154A 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva IT1271486B (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
CN94193726A CN1041524C (zh) 1993-10-12 1994-05-16 由c-活性蛋白质片段衍生的寡肽及其药物组合物
PCT/EP1994/001574 WO1995010531A1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments
ES94916966T ES2185652T3 (es) 1993-10-12 1994-05-16 Oligopeptidos derivados de fragmentos de proteinas c-reactiva.
DE69431603T DE69431603T2 (de) 1993-10-12 1994-05-16 Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins
JP50541495A JP3221881B2 (ja) 1993-10-12 1994-05-16 C反応性タンパク質断片から誘導されたオリゴペプチド
PT94916966T PT723552E (pt) 1993-10-12 1994-05-16 Oligopeptidos derivados de fragmentos de proteina reactiva c
CA002173939A CA2173939C (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments
US08/624,405 US6057295A (en) 1993-10-12 1994-05-16 Oligopeptides derived from C-reactive protein fragments
HU9600934A HUT75538A (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments
AU68441/94A AU684511B2 (en) 1993-10-12 1994-05-16 Oligopeptides derived from C-reactive protein fragments
KR1019960701879A KR100363408B1 (ko) 1993-10-12 1994-05-16 C-반응성단백질단편으로부터유도된올리고펩티드
AT94916966T ATE226591T1 (de) 1993-10-12 1994-05-16 Oligopeptide hergeleitet von fragmenten des c- reaktiven proteins
DK94916966T DK0723552T3 (da) 1993-10-12 1994-05-16 Oligopeptider afledt af fragmenter af C-reaktivt protein
EP94916966A EP0723552B1 (en) 1993-10-12 1994-05-16 Oligopeptides derived from c-reactive protein fragments
IL10976194A IL109761A0 (en) 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments
ZA943610A ZA943610B (en) 1993-10-12 1994-05-24 Oligopeptides derived from c-reactive protein fragments
FI961584A FI961584A (fi) 1993-10-12 1996-04-11 C-reaktiivisista proteiinifragmenteista johdetut oligopeptidit
NO961423A NO961423L (no) 1993-10-12 1996-04-11 Oligopeptider avledet fra C-reaktive proteinfragmenter
US09/439,164 US6342481B1 (en) 1993-10-12 1999-11-12 Oligopeptides derived from C-reactive protein fragments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Publications (3)

Publication Number Publication Date
ITMI932154A0 true ITMI932154A0 (it) 1993-10-12
ITMI932154A1 ITMI932154A1 (it) 1995-04-12
IT1271486B IT1271486B (it) 1997-05-28

Family

ID=11367010

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI932154A IT1271486B (it) 1993-10-12 1993-10-12 Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva

Country Status (19)

Country Link
US (1) US6057295A (it)
EP (1) EP0723552B1 (it)
JP (1) JP3221881B2 (it)
KR (1) KR100363408B1 (it)
CN (1) CN1041524C (it)
AT (1) ATE226591T1 (it)
AU (1) AU684511B2 (it)
CA (1) CA2173939C (it)
DE (1) DE69431603T2 (it)
DK (1) DK0723552T3 (it)
ES (1) ES2185652T3 (it)
FI (1) FI961584A (it)
HU (1) HUT75538A (it)
IL (1) IL109761A0 (it)
IT (1) IT1271486B (it)
NO (1) NO961423L (it)
PT (1) PT723552E (it)
WO (1) WO1995010531A1 (it)
ZA (1) ZA943610B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342481B1 (en) * 1993-10-12 2002-01-29 Italfarmaco S.P.A. Oligopeptides derived from C-reactive protein fragments
EP1408031A1 (en) * 2002-10-09 2004-04-14 3 D Gene Pharma Pyrolidine derivatives useful in treatment of hepatitis C virus infection
EP2350118B1 (en) 2008-09-19 2016-03-30 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
DK2526119T3 (en) 2010-01-19 2018-07-30 Harvard College Manipulated opsonin for pathogen detection and treatment
CA2842321C (en) 2011-07-18 2022-05-03 President And Fellows Of Harvard College Engineered microbe-targeting molecules and uses thereof
EP2976642A4 (en) 2013-03-15 2016-09-21 Harvard College METHODS AND COMPOSITIONS FOR IMPROVING THE DETECTION AND / OR CAPTURE OF A TARGET ENTITY
AU2014268603B2 (en) 2013-05-21 2018-03-22 President And Fellows Of Harvard College Engineered heme-binding compositions and uses thereof
EP3083658B1 (en) 2013-12-18 2019-05-08 President and Fellows of Harvard College Crp capture/detection of gram positive bacteria
EP3331549B1 (en) 2015-08-06 2020-12-23 President and Fellows of Harvard College Improved microbe-binding molecules and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2945239A1 (de) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Oligopeptide, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
US4353823A (en) * 1981-09-01 1982-10-12 Chipens Gunar I Synthetic analog of tuftisin
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
DE3783280T2 (de) * 1986-07-16 1993-05-06 Eniricerche Spa Teilweise retro-invertierte analoge des tuftsin, methode zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
IT1254883B (it) * 1992-04-16 1995-10-11 Italfarmaco Spa Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Also Published As

Publication number Publication date
JP3221881B2 (ja) 2001-10-22
DE69431603T2 (de) 2003-03-13
FI961584A0 (fi) 1996-04-11
AU6844194A (en) 1995-05-04
AU684511B2 (en) 1997-12-18
CA2173939A1 (en) 1995-04-20
ZA943610B (en) 1995-01-25
HU9600934D0 (en) 1996-08-28
EP0723552A1 (en) 1996-07-31
DK0723552T3 (da) 2003-02-24
IT1271486B (it) 1997-05-28
FI961584A (fi) 1996-04-11
NO961423D0 (no) 1996-04-11
JPH09503200A (ja) 1997-03-31
PT723552E (pt) 2003-02-28
CN1133048A (zh) 1996-10-09
ITMI932154A1 (it) 1995-04-12
WO1995010531A1 (en) 1995-04-20
ATE226591T1 (de) 2002-11-15
CA2173939C (en) 2002-08-27
EP0723552B1 (en) 2002-10-23
DE69431603D1 (de) 2002-11-28
HUT75538A (en) 1997-05-28
IL109761A0 (en) 1994-08-26
US6057295A (en) 2000-05-02
KR100363408B1 (ko) 2003-02-11
NO961423L (no) 1996-06-10
CN1041524C (zh) 1999-01-06
ES2185652T3 (es) 2003-05-01

Similar Documents

Publication Publication Date Title
DE69434520D1 (de) Biotinylierung von proteinen
MA23856A1 (fr) Recombinant obese (ob) proteines
DE4393381T1 (de) Peptide
NO972494D0 (no) Nye pinnsvin-avledete polypeptider
DE69532475D1 (de) Krebs hemmende peptide
DE69632366D1 (de) Probenfördereinrichtung
DE69411795D1 (de) Bauelemente
DK6893D0 (da) Peptid
DE69310216D1 (de) Schraubenverdichter
DK111489D0 (da) Peptider
NO985680D0 (no) Peptidderivater
LV10962A (lv) Jauni peptidi
ITMI932154A0 (it) Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE69413606D1 (de) Endothelinantagonistische Peptide
FI940109A0 (fi) Peptidejä
NO983849L (no) Peptidderivater
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
BR9606237A (pt) Material de armamento e reflatário monolítico usando o reflatário
DE69412346D1 (de) Linsenprüfvorrichtung
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
KR950001554U (ko) 왕복동식 압축기
NO961101D0 (no) Stempel
DE69429953D1 (de) Analysegerät mit Glimmentladung
DE69612804D1 (de) Schraubenverdichter
ITMI920939A0 (it) Tetrapeptidi parzialmente modificati e retroinvertiti, analoghi di frammenti della proteina c-reattiva.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971017